SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently facing significant volatility driven by a combination of geopolitical tensions, including concerns over Middle Eastern supply chains, and legal headwinds stemming from a jury verdict regarding past investor disclosures. Market participants are actively debating the company's long-term outlook, with discussion focused on the potential impact of high-cost 'Terafab' infrastructure plans on future profitability versus the long-term potential of its AI and robotics initiatives.

AleAnna, Inc. operates as a technology-driven energy company, which engages in supplying low-carbon natural gas and renewable natural gas to Italy. The company was founded in 2007 and is headquartered in Dallas, TX.

AleAnna Inc. - Ordinary Shares - Class A

AleAnna is surging as a primary beneficiary of the ongoing Middle East energy crisis, with the community closely tracking the potential for a massive short squeeze driven by extremely low float and record-breaking volume. Investors are hyper-focused on the company's natural gas assets in Italy as a critical energy security play, while the message boards are buzzing with intense debate over potential warrant exercises and whether the stock's momentum can mirror past sector runners.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund (USO) is trending as geopolitical volatility in the Middle East intensifies following a high-stakes 48-hour ultimatum by the U.S. regarding the Strait of Hormuz. The community is actively debating whether energy prices will continue to spike due to potential supply infrastructure disruptions or if the market has already reached a short-term peak as diplomatic chatter and military deployment news create deep uncertainty.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is experiencing a sharp, volatile sell-off as investors pivot away from traditional safe-haven assets toward energy and equities amid ongoing conflict in the Middle East and rising U.S. Treasury yields. The community is actively debating whether this decline represents a manipulative 'rug pull' by institutions or a broader liquidity crisis, with many traders questioning the asset's traditional role as an inflation hedge while simultaneously scouting for 'buy the dip' opportunities.

Guardian Metal Resources Plc engages in mining activities in the jurisdiction of Nevada. It focuses on making strategic metal discoveries across its broad project portfolio. Its projects include Pilot Mountain, Tempiute, Golconda, Garfield, Kibby Basin, and Stonewall. The company was founded on April 22, 2021 and is headquartered in London, the United Kingdom.

Guardian Metal Resources Plc - ADR

Guardian Metal Resources

Guardian Metal Resources is attracting intense community interest as it transitions to regular-way trading on the NYSE American, with investors speculating on potential momentum and liquidity swings associated with its low-float IPO status. Market participants are actively monitoring brokerage data and share availability while weighing the company's prospects within the broader metals mining sector.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

Market participants are reacting to the intensifying geopolitical standoff between the U.S. and Iran following a 48-hour ultimatum, driving significant volatility and concerns over energy security. The community is actively debating the potential for a market reversal, with many traders analyzing technical support levels and hedging strategies while clashing over the broader implications of these tensions on global economic stability.

Barrick Mining Corp. engages in the production and sale of gold, copper, and related activities. It also provides exploration and mining development. It operates through the following business segments: Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, Bulyanhulu, and Other Mines. The company was founded by Peter D. Munk in 1983 and is headquartered in Toronto, Canada.

Barrick Mining Corp.

Barrick Mining Corp

Barrick Mining is trending as investors digest record quarterly results marked by a 140% dividend increase and a major IPO plan for its North American gold assets amid a bullish environment for gold prices. Market participants are actively discussing the stock's long-term valuation potential and dividend growth relative to the broader commodities rally.

Synopsys, Inc. engages in the provision of electronic design automation (EDA) software that engineers use to design and test integrated circuits (ICs). It also offers semiconductor intellectual property (IP) products. It operates through the Design Automation and Design IP segments. The Design Automation segment includes silicon design, verification of products and services, and Ansys products, and system integration of products and services. The Design IP segment refers to interface, foundation, security, and embedded processor IP, IP subsystems, and IP implementation services that serve companies primarily in the semiconductor and electronics industries. The company was founded by Aart J. de Geus, Bill Krieger, Dave Gregory, and Rick Rudell in December 1986 and is headquartered in Sunnyvale, CA.

Synopsys, Inc.

Synopsys Inc

Synopsys is trending following news that Elliott Investment Management has built a multibillion-dollar stake in the company, with investors discussing the potential for the activist fund to push for better monetization and improved margins. The community is actively debating the company's valuation relative to the broader semiconductor sector and whether it can effectively leverage its AI-driven design tools to maintain its market position.

Alcoa Corp. engages in the bauxite mining, alumina refining, and aluminum smelting and casting. It operates through the Alumina and Aluminum segments. The Alumina segment consists of a refining system, including the mining of bauxite, which is then refined into alumina, a compound of aluminum and oxygen that is the raw material used by smelters to produce aluminum metal. The Aluminum segment is composed of smelting and casthouse system. The company was founded by Charles Martin Hall on July 9, 1886 and is headquartered in Pittsburgh, PA.

Alcoa Corp

Alcoa is drawing intense attention as traders debate the impact of potential U.S. metal tariffs and supply chain risks from geopolitical tensions, with some community members eyeing a technical breakout while others remain cautious due to volatile energy costs and shifting trade policies. The stock is a focal point for institutional option activity, as traders speculate on whether recent operational shifts and data center asset monetization can drive long-term growth despite current margin pressures.

Crane Harbor Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on January 2, 2025 and is headquartered in Philadelphia, PA.

Crane Harbor Acquisition Corp. - Ordinary Shares - Class A

Crane Harbor Acquisition Corp.

Crane Harbor Acquisition Corp. is trending as shareholders recently approved its merger with Xanadu Quantum Technologies, a milestone expected to establish the first publicly traded photonic quantum computing company under the ticker XNDU. Community discussion is heavily focused on the deal's potential for a low-float short-term squeeze, strategic partnerships with major tech industry leaders, and potential government funding support.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Given Consensus Recommendation of "Reduce" by Brokerages

Shares of Pliant Therapeutics, Inc. (NASDAQ:PLRX - Get Free Report) have earned an average rating of "Reduce" from the five analysts that are currently covering the company, Marketbeat reports. Two research analysts have rated the stock with a sell rating, two have given a hold rating and one has...

Canaccord Genuity Group Issues Pessimistic Forecast for Pliant Therapeutics (NASDAQ:PLRX) Stock Price

Canaccord Genuity Group lowered their price target on Pliant Therapeutics from $4.00 to $3.00 and set a "hold" rating for the company in a research note on Friday...

Pliant Therapeutics (NASDAQ:PLRX) Issues Quarterly Earnings Results

Pliant Therapeutics (NASDAQ:PLRX - Get Free Report) announced its quarterly earnings data on Wednesday. The company reported ($0.38) earnings per share (EPS) for the quarter, topping the consensus...

Pliant Therapeutics Pivots to Oncology, Highlights Early PLN-101095 Responses at Oppenheimer Conference

Pliant Therapeutics (NASDAQ:PLRX) used its presentation at Oppenheimer's 36th Annual Healthcare Conference to outline its strategic transition toward oncology following the discontinuation of its...

Pliant Therapeutics (PLRX) Expected to Announce Quarterly Earnings on Monday

Pliant Therapeutics (NASDAQ:PLRX) will be releasing its Q4 2025 earnings before the market opens on Monday, March 2. (View Earnings Report at...

Pliant Therapeutics (NASDAQ:PLRX) CEO Sells $114,400.00 in Stock

Pliant Therapeutics, Inc. (NASDAQ:PLRX - Get Free Report) CEO Bernard Coulie sold 89,375 shares of the business's stock in a transaction that occurred on Tuesday, January 20th. The stock was sold at...

Bernard Coulie Sells 89,375 Shares of Pliant Therapeutics (NASDAQ:PLRX) Stock

Pliant Therapeutics, Inc. (NASDAQ:PLRX - Get Free Report) CEO Bernard Coulie sold 89,375 shares of the firm's stock in a transaction on Tuesday, January 20th. The stock was sold at an average price...

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Given Average Rating of "Reduce" by Analysts

Pliant Therapeutics, Inc. (NASDAQ:PLRX - Get Free Report) has been assigned an average recommendation of "Reduce" from the fourteen ratings firms that are currently covering the stock, MarketBeat...

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Short Interest Down 20.3% in December

Pliant Therapeutics, Inc. (NASDAQ:PLRX - Get Free Report) was the target of a large decline in short interest during the month of December. As of December 15th, there was short interest totaling...

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Given Average Rating of "Reduce" by Brokerages

Pliant Therapeutics, Inc. (NASDAQ:PLRX - Get Free Report) has earned a consensus rating of "Reduce" from the fourteen ratings firms that are currently covering the firm, MarketBeat reports. Two...

Pliant Therapeutics, Inc. engages in the discovery, development and commercialization of therapies for fibrotic diseases. It offers a product discovery engine. The company is pursuing drug development programs for a range of fibrotic diseases, focusing on tissue-specific integrin modulation and TGF-ß1 signaling inhibition. The company was founded by Bradley Backes, Bill De Grado, Hal Chapman, and Dean Sheppard in June 2015 and is headquartered in South San Francisco, CA.

PLRX
Pliant Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PLRX News

PLRXPliant Therapeutics Inc